Powerful Science,
Natural Results

 
home-page-woman-02-06-2019.jpg
 

Our Story

LifeSprout is developing revolutionary synthetic soft tissues for aesthetic and reconstructive medicine. Leveraging recent breakthroughs in materials science, we have created a platform that looks and behaves like the body’s own tissues. We are turning this into a suite of products for the millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease. Our next generation products enhance form and function with minimal downtime and superb results. 


Our Vision

We are developing best-in-class solutions to the challenges of soft tissue restoration. We aim for all patients to be whole. To be healthy. To be their best selves.


Our Values

We are a team of passionate scientists, clinicians, and entrepreneurs. We are driven by integrity, excellence, creativity, tenacity, and joy.


Milestones

2018

November
LifeSprout completes GMP production of first injectable products

October
LifeSprout clarifies PMA pathway in pre-IDE meeting with FDA

February
LifeSprout closes Series Seed Financing with major venture capital and strategic leads ($6,500,000)

2017

October
LifeSprout wins Johnson & Johnson QuickFire Device Challenge and AngelMD Sponsorship ($275,000)

September
LifeSprout wins Maryland Stem Cell Research and Commercialization Fund Award ($300,000)

January
Exclusive license secured to foundational intellectual property from Johns Hopkins University

2016

September
Team receives major sponsored research award from the Abell Foundational ($660,000)

July
Team wins translational grant funding from Johns Hopkins and the State of Maryland ($305,000)

2015

September
LifeSprout formed